| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JPEDS.2010.02.024 |
| P698 | PubMed publication ID | 20400099 |
| P50 | author | Lisa J Herrinton | Q91306296 |
| Susan Hutfless | Q40183258 | ||
| G. Allen Finley | Q60780533 | ||
| P2093 | author name string | Anthony Wong | |
| James D Lewis | |||
| Geraldine S Perry | |||
| Liyan Liu | |||
| Nicole Flowers | |||
| James E Allison | |||
| Oren Abramson | |||
| Fernando S Velayos | |||
| Robert Cannon | |||
| Michael Durant | |||
| Pratima Kodali | |||
| Erin McCroskey | |||
| Venessa Tavares | |||
| William Mow | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | California | Q99 |
| inflammatory bowel diseases | Q917447 | ||
| inflammation | Q101991 | ||
| P304 | page(s) | 233-239.e1 | |
| P577 | publication date | 2010-04-18 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006 | |
| P478 | volume | 157 |
| Q46572722 | A lipidomics investigation into the intervention of celastrol in experimental colitis. |
| Q35901531 | A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease. |
| Q34417015 | Canadian Digestive Health Foundation Public Impact Series. Inflammatory bowel disease in Canada: Incidence, prevalence, and direct and indirect economic impact |
| Q36174814 | Challenges in designing a national surveillance program for inflammatory bowel disease in the United States |
| Q50872867 | Childhood onset of Crohn disease: experience from a university teaching hospital in Saudi Arabia. |
| Q37261147 | Contribution of higher risk genes and European admixture to Crohn's disease in African Americans |
| Q55506753 | Current global trends in the incidence of pediatric-onset inflammatory bowel disease. |
| Q34183403 | DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric ulcerative colitis. |
| Q48786898 | Diagnosis and management of inflammatory bowel disease in children. |
| Q35537121 | Diet in the pathogenesis and treatment of inflammatory bowel diseases |
| Q40061420 | Doppler US measurement of the superior mesenteric artery blood flow in children and adolescents. |
| Q90301477 | Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East |
| Q27025198 | Etiology of inflammatory bowel disease: a unified hypothesis |
| Q86959548 | GC-MS metabolomics on PPARα-dependent exacerbation of colitis |
| Q37267748 | Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases |
| Q38064356 | History of and current issues affecting surgery for pediatric ulcerative colitis |
| Q37691029 | Incidence and paris classification of pediatric inflammatory bowel disease |
| Q36983642 | Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study |
| Q40628494 | Increased Prevalence of Inflammatory Bowel Disease in Patients with Mutations in Genes Encoding the Receptor Subunits for TGFβ. |
| Q35657007 | Infections Requiring Hospitalization as Predictors of Pediatric-Onset Crohn's Disease and Ulcerative Colitis |
| Q30695348 | Inflammatory Bowel Disease in Children and Adolescents |
| Q51203885 | Inflammatory bowel disease in Chinese children: a multicenter analysis over a decade from Shanghai. |
| Q33805916 | Inflammatory bowel disease incidence in Czech children: A regional prospective study, 2000-2015 |
| Q49387093 | Large Registry Epidemiology in IBD. |
| Q35878997 | Loss of n-6 fatty acid induced pediatric obesity protects against acute murine colitis |
| Q87901868 | Medical and Surgical Management of Pediatric Ulcerative Colitis |
| Q47592510 | Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay |
| Q40249669 | Paediatric inflammatory bowel disease in a multiracial Asian country |
| Q99565979 | Patterns of Complementary and Alternative Medicine Use in Saudi Arabian Patients With Inflammatory Bowel Disease: A Cross-Sectional Study |
| Q40912671 | Perinatal vitamin D levels are not associated with later risk of developing pediatric-onset inflammatory bowel disease: a Danish case-cohort study |
| Q41989273 | Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease |
| Q36113666 | Plasmablast frequency and trafficking receptor expression are altered in pediatric ulcerative colitis |
| Q35684726 | Prenatal and perinatal characteristics associated with pediatric-onset inflammatory bowel disease. |
| Q38556000 | Prevalence of Inflammatory Bowel Disease Among Patients with Autism Spectrum Disorders |
| Q36265752 | Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study |
| Q26996289 | Quality improvement in pediatric inflammatory bowel disease: moving forward to improve outcomes |
| Q92310083 | Recent advances in understanding and managing pediatric inflammatory bowel disease |
| Q36622034 | Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population. |
| Q38068962 | Recommendations for identifying Crohn's disease patients with poor prognosis |
| Q89714944 | Regional Incidence of Inflammatory Bowel Disease in a Czech Pediatric Population: 16 Years of Experience (2002-2017) |
| Q39737572 | Rising incidence of pediatric inflammatory bowel disease in Scotland. |
| Q99234081 | Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease |
| Q38583927 | The emerging global epidemic of paediatric inflammatory bowel disease--causes and consequences |
| Q37678171 | The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study |
| Q82609061 | “Omics” as the filtering gateway between environment and phenotype: The inflammatory bowel diseases example |
Search more.